News

Nova (NASDAQ:NVMI) Delivers Strong Q4 Numbers, Provides Optimistic Revenue Guidance for Next Quarter

Semiconductor quality control company Nova (NASDAQ:NVMI) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 45.1% year on year to $194.8 million. On top of that, next quarter’s revenue guidance ($210 million at the midpoint) was surprisingly good and 10.6% above what analysts were expecting. Its non-GAAP profit of $1.94 per share was 6.6% above analysts’ consensus estimates.

Zoetis (NYSE:ZTS) Posts Q4 Sales In Line With Estimates But Stock Drops

Animal health company Zoetis (NYSE:ZTS) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.7% year on year to $2.32 billion. On the other hand, the company’s full-year revenue guidance of $9.3 billion at the midpoint came in 2.8% below analysts’ estimates. Its non-GAAP profit of $1.40 per share was 4.7% above analysts’ consensus estimates.

Bruker’s (NASDAQ:BRKR) Q4 Sales Top Estimates But Full-Year Sales Guidance Misses Expectations

Scientific instrument company Bruker (NASDAQ:BRKR). reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 14.6% year on year to $979.6 million. On the other hand, the company’s full-year revenue guidance of $3.51 billion at the midpoint came in 1.8% below analysts’ estimates. Its non-GAAP profit of $0.76 per share was 3.2% above analysts’ consensus estimates.